CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.
May 27th 2024
Here’s a look at therapies the FDA approved in the blood cancer space over the last few months.
MRD Measurement Shows Promise for Making Informed Treatment Decisions in Myeloma
December 15th 2019At CURE’s Educated Patient Summit on Multiple Myeloma, Dr. Barry Paul discussed the role of minimal residual disease measurement and how it may be used in the future to determine treatment options for patients with myeloma.
The Importance of Clinical Trials in Multiple Myeloma
December 7th 2019As patients progress through therapy, it is important that oncologists not disregard the novel agents that are currently being investigated in clinical trials, according to Memorial Sloan Kettering Cancer Center’s Dr. Sham Mailankody.
FDA Approves Frontline Darzalex Regimen to Treat Patients With Multiple Myeloma
September 26th 2019The four-drug regimen of Darzalex in combination with Velcade, Thalomid and dexamethasone has been approved for the treatment of newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant.